Senior insider sale
President, R&D & CMO at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$4.42M
105K shares
What this filing means
BERNSTEIN HAROLD plans to sell 105K shares of MAZE THERAPEUTICS, INC. valued at approximately $4.42M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001950047-25-010743
Officer· President, R&D & CMO
Since Mar 2026
105K
Shares to sell
$4.42M
Approx. market value
105K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
12/29/2025
105KTotal acquired105K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/29/2025 | Exercise of Stock Options Cash | 105K | — |
| Total | 105K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
105K
Market value
$4.42M
12/29/2025
Total
Units
105K
Value
$4.42M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/29/2025 | 105K | $4.42M | NASDAQ | Planned |
| Total | 105K | $4.42M | ||